Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug;29(8):2275-2282.
doi: 10.1111/ene.15356. Epub 2022 Apr 25.

Classification of patients with embolic stroke of undetermined source into cardioembolic and non-cardioembolic profile subgroups

Affiliations

Classification of patients with embolic stroke of undetermined source into cardioembolic and non-cardioembolic profile subgroups

Max Christian Martin et al. Eur J Neurol. 2022 Aug.

Abstract

Background and purpose: It is currently thought that embolic stroke of undetermined source (ESUS) has diverse underlying hidden etiologies, of which cardioembolism is one of the most important. The subgroup of patients with this etiology could theoretically benefit from oral anticoagulation, but it remains unclear if these patients can be correctly identified from other ESUS subgroups and which markers should be used. We aimed to determine whether a machine-learning (ML) model could discriminate between ESUS patients with cardioembolic and those with non-cardioembolic profiles using baseline demographic and laboratory variables.

Methods: Based on a prospective registry of consecutive ischemic stroke patients submitted to acute revascularization therapies, an ML model was trained using the age, sex and 11 selected baseline laboratory parameters of patients with known stroke etiology, with the aim of correctly identifying patients with cardioembolic and non-cardioembolic etiologies. The resulting model was used to classify ESUS patients into those with cardioembolic and those with non-cardioembolic profiles.

Results: The ML model was able to distinguish patients with known stroke etiology into cardioembolic or non-cardioembolic profile groups with excellent accuracy (area under the curve = 0.82). When applied to ESUS patients, the model classified 40.3% as having cardioembolic profiles. ESUS patients with cardioembolic profiles were older, more frequently female, more frequently had hypertension, less frequently were active smokers, had higher CHA2 DS2 -VASc (Congestive heart failure or left ventricular systolic dysfunction, Hypertension, Age ≥ 75 [doubled], Diabetes, Stroke/transient ischemic attack [doubled], Vascular disease, Age 65-74, and Sex category) scores, and had more premature atrial complexes per hour.

Conclusions: An ML model based on baseline demographic and laboratory variables was able to classify ESUS patients into cardioembolic or non-cardioembolic profile groups and predicted that 40% of the ESUS patients had a cardioembolic profile.

Keywords: cardioembolism; embolic stroke of undetermined source; ischemic stroke; machine learning; stroke.

PubMed Disclaimer

References

REFERENCES

    1. Hart RG, Catanese L, Perera KS, Ntaios G, Connolly SJ. Embolic stroke of undetermined source: a systematic review and clinical update. Stroke. 2017;48(4):867-872. doi:10.1161/STROKEAHA.116.016414
    1. Bembenek JP, Karlinski MA, Kurkowska-Jastrzebska I, Czlonkowska A. Embolic strokes of undetermined source in a cohort of Polish stroke patients. Neurol Sci. 2018;39:1041-1047. doi:10.1007/s10072-018-3322-5
    1. Tsivgoulis G, Kargiotis O, Katsanos AH, et al. Incidence, characteristics and outcomes in patients with embolic stroke of undetermined source: a population-based study. J Neurol Sci. 2019;401:5-11. doi:10.1016/j.jns.2019.04.008
    1. Ntaios G, Papavasileiou V, Milionis H, et al. Embolic strokes of undetermined source in the Athens stroke registry: an outcome analysis. Stroke. 2015;46(8):2087-2093. doi:10.1161/STROKEAHA.115.009334
    1. Hart RG, Diener H-C, Coutts SB, et al. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol. 2014;13(4):429-438. doi:10.1016/s1474-4422(13)70310-7

Publication types

LinkOut - more resources